KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves
Authors
Keywords
-
Journal
BMC Medical Research Methodology
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-03
DOI
10.1186/s12874-022-01567-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
- (2021) Nicholas L Syn et al. LANCET
- IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves
- (2021) Na Liu et al. BMC Medical Research Methodology
- Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples
- (2021) Anup K. Amatya et al. CLINICAL CANCER RESEARCH
- Intra-arterial therapy for unresectable colorectal liver metastases: A meta-analysis
- (2021) Joseph J. Zhao et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
- (2021) Jong-Mu Sun et al. LANCET
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma
- (2021) Joseph J. Zhao et al. JOURNAL OF CLINICAL ONCOLOGY
- Review of precision cancer medicine: Evolution of the treatment paradigm
- (2020) Apostolia M. Tsimberidou et al. CANCER TREATMENT REVIEWS
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Negative Predictive Biomarkers in Colorectal Cancer: PRESSING Ahead
- (2019) Raghav Sundar et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Towards precision medicine
- (2016) Euan A. Ashley NATURE REVIEWS GENETICS
- MatchIt: Nonparametric Preprocessing for Parametric Causal Inference
- (2015) Daniel E. Ho et al. Journal of Statistical Software
- External validation of a Cox prognostic model: principles and methods
- (2013) Patrick Royston et al. BMC Medical Research Methodology
- Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
- (2013) Patrick Royston et al. BMC Medical Research Methodology
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
- (2012) Patricia Guyot et al. BMC Medical Research Methodology
- A Systematic Review of Propensity Score Methods in the Social Sciences
- (2011) Felix J. Thoemmes et al. MULTIVARIATE BEHAVIORAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started